A Clofarabine-Based Bridging Regimen in Patients With Relapsed ALL and Persistent Minimal Residual Disease (MRD)
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2013.195
Full Text
Open PDFAbstract
Available in full text
Date
December 9, 2013
Authors
Publisher
Springer Science and Business Media LLC